[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)
date : 3/3/2023
Tags: Other activities
Health and Global Policy Institute (HGPI) Board Member and CEO Mr. Ryoji Noritake has been awarded the FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences. Mr. Noritake was recognized for his contributions to the development of a mature civil society by creating opportunities for diverse stakeholders in society and the parties most affected in various areas to come together for exchanges of opinion that surpass the positions of individuals. At Mr. Noritake’s request, the monetary prize from the award has been donated to HGPI.
■ Introducing the Takemi Memorial Award for Research in Seizon and Life Sciences
The Takemi Memorial Award for Research in Seizon and Life Sciences recognizes individuals or groups who will serve as future leaders of Japan and have made noteworthy achievements through innovative research and practical activities in basic, clinical, and social medicine in life sciences or related fields. (From the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.)
For further details, please refer to the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)